Literature DB >> 12815747

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans.

Xingguang Luo1, Henry R Kranzler, Hongyu Zhao, Joel Gelernter.   

Abstract

Our objective was to investigate the relationship between the gene encoding the mu-opioid receptor (OPRM1) and susceptibility to substance dependence in European-American (EA) and African-American (AA) subjects. Eight single nucleotide polymorphisms (SNPs) at the OPRM1 locus, i.e., -2044C/A, -1793T/A, -1699insT, -1469T/C, -1320A/G, -111C/T, +17C/T (Ala6Val), and +118A/G (Asn40Asp) were genotyped in 676 subjects: 318 EA subjects and 124 AA subjects with substance dependence, and 179 EA normal controls, and 55 AA normal controls. Affection status was defined by each unique combination of alcohol, cocaine, and opioid dependence and analysis of association examined in relation to the possible combinations. We used a newly implemented permutation method to evaluate statistical significance. In EAs, a significant difference in haplotype frequency distributions was found between controls and "alcohol + opioid" dependent patients (P = 0.0036). This finding is also supported by logistic regression analysis and a simulation method. The frequencies of allele -2044A and haplotypes including -2044A are higher in these patients than in controls. In AAs, no allele, haplotype, or genotype frequencies were significantly different between cases and controls. There were highly significant differences in the allele, haplotype, and genotype frequencies between EA and AA controls. Four of the variants [-1793T/A, -1699insT, -1320A/G, and -111C/T] are in virtually complete linkage disequilibrium (LD) to compose a sequence pattern, which does not associate with any of the seven categories of substance dependence. In EAs, allele -2044A and haplotypes that include -2044A are the susceptibility allele and haplotypes for substance dependence. These findings suggest that OPRM1 may play a role in the pathophysiology of substance dependence and this role is population- and diagnosis-specific. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815747     DOI: 10.1002/ajmg.b.20034

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  46 in total

1.  Incorporating genotyping uncertainty in haplotype inference for single-nucleotide polymorphisms.

Authors:  Hosung Kang; Zhaohui S Qin; Tianhua Niu; Jun S Liu
Journal:  Am J Hum Genet       Date:  2004-02-13       Impact factor: 11.025

2.  A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women.

Authors:  Howard A Crystal; Sara Hamon; Matthew Randesi; Judith Cook; Kathryn Anastos; Jason Lazar; Chenglong Liu; Leigh Pearce; Elizabeth Golub; Victor Valcour; Kathleen M Weber; Susan Holman; Ann Ho; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2010-11-11       Impact factor: 4.280

3.  Genomewide linkage scan for opioid dependence and related traits.

Authors:  Joel Gelernter; Carolien Panhuysen; Marsha Wilcox; Victor Hesselbrock; Bruce Rounsaville; James Poling; Roger Weiss; Susan Sonne; Hongyu Zhao; Lindsay Farrer; Henry R Kranzler
Journal:  Am J Hum Genet       Date:  2006-03-16       Impact factor: 11.025

4.  Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.

Authors:  Katarina Drakenberg; Andrej Nikoshkov; Monika Cs Horváth; Pernilla Fagergren; Anna Gharibyan; Kati Saarelainen; Sadia Rahman; Ingrid Nylander; Georgy Bakalkin; Jovan Rajs; Eva Keller; Yasmin L Hurd
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

5.  Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

Authors:  Huiping Zhang; Xingguang Luo; Henry R Kranzler; Jaakko Lappalainen; Bao-Zhu Yang; Evgeny Krupitsky; Edwin Zvartau; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2006-02-13       Impact factor: 6.150

6.  The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.

Authors:  H Zhang; H R Kranzler; B-Z Yang; X Luo; J Gelernter
Journal:  Mol Psychiatry       Date:  2007-07-10       Impact factor: 15.992

7.  Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene.

Authors:  Jonathan Covault; Joel Gelernter; Kevin Jensen; Raymond Anton; Henry R Kranzler
Journal:  Neuropsychopharmacology       Date:  2007-05-16       Impact factor: 7.853

8.  Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis.

Authors:  Stephen J Glatt; Chad Bousman; Richard S Wang; Kenton K Murthy; Brinda K Rana; Jessica A Lasky-Su; Shao C Zhu; Ruimin Zhang; Jianhua Li; Bo Zhang; Jixiang Li; Michael J Lyons; Stephen V Faraone; Ming T Tsuang
Journal:  Drug Alcohol Depend       Date:  2007-04-09       Impact factor: 4.492

9.  NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent.

Authors:  Lingjun Zuo; Kesheng Wang; Xiang-Yang Zhang; John H Krystal; Chiang-Shan R Li; Fengyu Zhang; Heping Zhang; Xingguang Luo
Journal:  Drug Alcohol Depend       Date:  2013-02-28       Impact factor: 4.492

10.  Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Authors:  Toni-Kim Clarke; Richard C Crist; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'Brien; David W Oslin; Thomas N Ferraro; Falk W Lohoff; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2013-02-20       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.